Friday, 19 January 2018

Imaging grey matter atrophy to find the roots of disability

How do we measure nerve loss?

The imagers tell us it is grey matter loss that holds the key.

So what's new here?

Wednesday, 17 January 2018

Is HSCT for everyone, or not?

The HSCT zealots would want you to believe that HSCT is the solution to MS and that we the neurologists are preventing you from accessing this curative treatment. Are they correct? Or do we need evidence from randomised trials?



Monday, 15 January 2018

Imaging Demyelination, but am I being a bit thick?

A new report suggests that there is a new imaging agent for demyelination.

If we can image demyelination, remyelination trials get a whole lot easier.

However you asked, Has this study in animals cracked the nut?
Updated

Future Directions for Laboratory Animal Law in the US

Animals in Research is an Integral part of MS research.

Like or Loathe it, it is occurring, but times are changing.

Do you want to listen to a Day Webinar?

Future Directions for Laboratory Animal Law in the United States


Sunday, 14 January 2018

Making T reg cells. Explaining the daclizumab conundrum

How does daclicumab work?

Are immunologists fudging the mechanisms to keep dogma alive?

Friday, 12 January 2018

Newsflash: the wait is over ocrelizumab finally gets its EU marketing authorisation

If you have PPMS, and live in Europe, you are one step closer to having a disease-modifying therapy for your MS.


Guest post: FAIR data for next generation management of MS

Transforming the population based management of today into an individualized, personalized and precision level management is a major goal in research. I believe, the key to reach this next level is FAIR data.